Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Copayment reductions generate greater medication adherence in targeted patients.

Maciejewski ML, Farley JF, Parker J, Wansink D.

Health Aff (Millwood). 2010 Nov;29(11):2002-8. doi: 10.1377/hlthaff.2010.0571.

PMID:
21041739
2.

Value-based insurance design program in north Carolina increased medication adherence but was not cost neutral.

Maciejewski ML, Wansink D, Lindquist JH, Parker JC, Farley JF.

Health Aff (Millwood). 2014 Feb;33(2):300-8. doi: 10.1377/hlthaff.2013.0260.

PMID:
24493774
3.

Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.

Maciejewski ML, Bryson CL, Perkins M, Blough DK, Cunningham FE, Fortney JC, Krein SL, Stroupe KT, Sharp ND, Liu CF.

Am J Manag Care. 2010 Jan 1;16(1):e20-34.

4.

Medication adherence changes following value-based insurance design.

Farley JF, Wansink D, Lindquist JH, Parker JC, Maciejewski ML.

Am J Manag Care. 2012 May;18(5):265-74.

PMID:
22694064
5.

The effect of a large regional health plan's value-based insurance design program on statin use.

Frank MB, Fendrick AM, He Y, Zbrozek A, Holtz N, Leung S, Chernew ME.

Med Care. 2012 Nov;50(11):934-9. doi: 10.1097/MLR.0b013e31826c8630.

PMID:
23047782
6.

A value-based insurance design program at a large company boosted medication adherence for employees with chronic illnesses.

Gibson TB, Wang S, Kelly E, Brown C, Turner C, Frech-Tamas F, Doyle J, Mauceri E.

Health Aff (Millwood). 2011 Jan;30(1):109-17. doi: 10.1377/hlthaff.2010.0510.

PMID:
21209446
7.

Impact of decreasing copayments on medication adherence within a disease management environment.

Chernew ME, Shah MR, Wegh A, Rosenberg SN, Juster IA, Rosen AB, Sokol MC, Yu-Isenberg K, Fendrick AM.

Health Aff (Millwood). 2008 Jan-Feb;27(1):103-12. doi: 10.1377/hlthaff.27.1.103.

PMID:
18180484
8.

Cost-sharing and adherence to antihypertensives for low and high adherers.

Yoon J, Ettner SL.

Am J Manag Care. 2009 Nov;15(11):833-40.

9.

Effects of increased patient cost sharing on socioeconomic disparities in health care.

Chernew M, Gibson TB, Yu-Isenberg K, Sokol MC, Rosen AB, Fendrick AM.

J Gen Intern Med. 2008 Aug;23(8):1131-6. doi: 10.1007/s11606-008-0614-0. Epub 2008 Apr 29.

10.

Cost-sharing effects on adherence and persistence for second-generation antipsychotics in commercially insured patients.

Gibson TB, Jing Y, Kim E, Bagalman E, Wang S, Whitehead R, Tran QV, Doshi JA.

Manag Care. 2010 Aug;19(8):40-7.

11.

Impact of statin copayments on adherence and medical care utilization and expenditures.

Gibson TB, Mark TL, Axelsen K, Baser O, Rublee DA, McGuigan KA.

Am J Manag Care. 2006 Dec;12 Spec no.:SP11-9.

12.

Adherence to biologics demands greater attention.

Reinke T.

Manag Care. 2011 May;20(5):39-41. No abstract available.

13.
14.

The effects of prescription drug copayments on statin adherence.

Gibson TB, Mark TL, McGuigan KA, Axelsen K, Wang S.

Am J Manag Care. 2006 Sep;12(9):509-17.

15.

Value-based insurance design in Medicare.

Encinosa WE.

Appl Health Econ Health Policy. 2009;7(3):149-54. doi: 10.2165/11318720-000000000-00000.

PMID:
19799469
16.

Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care.

Taira DA, Wong KS, Frech-Tamas F, Chung RS.

Am J Manag Care. 2006 Nov;12(11):678-83.

17.

Did copayment changes reduce health service utilization among CHIP enrollees? Evidence from Alabama.

Sen B, Blackburn J, Morrisey MA, Kilgore ML, Becker DJ, Caldwell C, Menachemi N.

Health Serv Res. 2012 Aug;47(4):1603-20. doi: 10.1111/j.1475-6773.2012.01384.x. Epub 2012 Feb 21.

18.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
19.

Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.

Cole JA, Norman H, Weatherby LB, Walker AM.

Pharmacotherapy. 2006 Aug;26(8):1157-64.

PMID:
16863491
20.

Cost sharing, adherence, and health outcomes in patients with diabetes.

Gibson TB, Song X, Alemayehu B, Wang SS, Waddell JL, Bouchard JR, Forma F.

Am J Manag Care. 2010 Aug;16(8):589-600.

Supplemental Content

Support Center